Document Detail


Genetic evidence that thyroid hormone is indispensable for prepubertal insulin-like growth factor-I expression and bone acquisition in mice.
MedLine Citation:
PMID:  22513648     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Understanding how bone growth is regulated by hormonal and mechanical factors during early growth periods is important for optimizing the attainment of peak bone mass to prevent or postpone the occurrence of fragility fractures later in life. Using genetic mouse models that are deficient in thyroid hormone (TH) (Tshr(-/-) and Duox2(-/-)), growth hormone (GH) (Ghrhr(lit/lit)), or both (Tshr(-/-); Ghrhr(lit/lit)), we demonstrate that there is an important period prior to puberty when the effects of GH are surprisingly small and TH plays a critical role in the regulation of skeletal growth. Daily administration of T3/T4 during days 5 to 14, the time when serum levels of T3 increase rapidly in mice, rescued the skeletal deficit in TH-deficient mice but not in mice lacking both TH and GH. However, treatment of double-mutant mice with both GH and T3/T4 rescued the bone density deficit. Increased body fat in the TH-deficient as well as TH/GH double-mutant mice was rescued by T3/T4 treatment during days 5 to 14. In vitro studies in osteoblasts revealed that T3 in the presence of TH receptor (TR) α1 bound to a TH response element in intron 1 of the IGF-I gene to stimulate transcription. In vivo studies using TRα and TRβ knockout mice revealed evidence for differential regulation of insulin-like growth factor (IGF)-I expression by the two receptors. Furthermore, blockade of IGF-I action partially inhibited the biological effects of TH, thus suggesting that both IGF-I-dependent and IGF-I-independent mechanisms contribute to TH effects on prepubertal bone acquisition.
Authors:
Weirong Xing; Kristen E Govoni; Leah Rae Donahue; Chandrasekhar Kesavan; Jon Wergedal; Carlin Long; J H Duncan Bassett; Apostolos Gogakos; Anna Wojcicka; Graham R Williams; Subburaman Mohan
Related Documents :
8630548 - Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines.
12388208 - Impaired ras membrane association and activation in pparalpha knockout mice after parti...
20663988 - Glucagon and lipid interactions in the regulation of hepatic ampk signaling and express...
10022238 - Peroxisome proliferator-activated receptor (ppar) alpha-regulated growth responses and ...
7700568 - Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth fact...
18188158 - Blockade of at1 receptor improves adipocyte differentiation in atherosclerotic and diab...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research     Volume:  27     ISSN:  1523-4681     ISO Abbreviation:  J. Bone Miner. Res.     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-04-19     Completed Date:  2012-09-27     Revised Date:  2014-04-08    
Medline Journal Info:
Nlm Unique ID:  8610640     Medline TA:  J Bone Miner Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1067-79     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 American Society for Bone and Mineral Research.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bone Development / genetics*
Cells, Cultured
Disease Models, Animal
Gene Expression Regulation, Developmental* / drug effects
Insulin-Like Growth Factor I / genetics*,  metabolism*
Mice
Mice, Inbred C57BL
Mice, Knockout
Osteoblasts / drug effects
Polymerase Chain Reaction
Puberty / physiology*
Thyroid Hormones / genetics,  metabolism*,  pharmacology
Grant Support
ID/Acronym/Agency:
AR 048139/AR/NIAMS NIH HHS; G0501486//Medical Research Council; G0800261//Medical Research Council; G0800359//Medical Research Council; R01 AR048139/AR/NIAMS NIH HHS; R01 AR048139-04/AR/NIAMS NIH HHS
Chemical
Reg. No./Substance:
0/Thyroid Hormones; 67763-96-6/Insulin-Like Growth Factor I
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Arbitrary shape surface Fresnel diffraction.
Next Document:  Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractur...